Institutional investors hold a majority ownership of LLY through the 65.44% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Pharmaceuticals: Major industry. Last, during the quarter ended September 2014, these large investors purchased a net $8.7 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
T. ROWE PRICE ASSOCIATES, INC. Bought 15.2 Million shares of Eli Lilly and Co
LORD, ABBETT & CO. LLC Bought 3.7 Million shares of Eli Lilly and Co
EATON VANCE MANAGEMENT Bought 3.5 Million shares of Eli Lilly and Co